{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:17Z","timestamp":1772166257019,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parathyroid carcinoma (PC) is a rare thyroid tumor. PC with sarcomatoid differentiation(PCSD) is even rarer and its exact etiology remains unclear. We here report a case of PCSD, and present the clinicopathological features and pathological diagnosis and review the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 71-year-old man presented with a mass of 4.5\u2009cm\u2009\u00d7\u20093.5\u2009cm in the right neck. The tumor was composed of nest-like transparent cells, and the septum had heterotypic rhabdoid cells with sarcomatoid differentiation. Immunophenotype was as follows: myogenic differentiation 1(MyoD1), myogenin and desmin were positive; clear cells were positive for chromogranin A(CGA), synaptophysin(Syn) and GATA-3; and Ki-67 proliferation index was 40%. Hematoxylin and eosin staining and immunohistochemistry were performed. The patient was diagnosed with PCSD, and died 6\u2009months after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PCSD is a rare type of primary parathyroid tumor with high malignancy and poor prognosis. Definitive diagnosis should be based on histopathological morphology and immunophenotype, and surgical treatment should be performed as soon as possible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-020-01060-5","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T10:03:32Z","timestamp":1607940212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Liang","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2164-5150","authenticated-orcid":false,"given":"Xiaojun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"11","key":"1060_CR1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.5858\/2009-0578-CCR.1","volume":"134","author":"D Carlson","year":"2010","unstructured":"Carlson D. Parathyroid pathology: hyperparathyroidism and parathyroid tumors. Arch Pathol Lab Med. 2010;134(11):1639\u201344.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"1060_CR2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/000313480206801015","volume":"68","author":"R Nacamuli","year":"2002","unstructured":"Nacamuli R, Rumore GJ, Clark G. Parathyroid carcinosarcoma: a previously unreported entity. Am Surg. 2002;68(10):900\u20133.","journal-title":"Am Surg"},{"key":"1060_CR3","first-page":"3679","volume":"12","author":"H Avital","year":"2011","unstructured":"Avital H, Avantika W, Gustavo FR, Jimmy H, Insoo S, Elliot M, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;12:3679\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"1060_CR4","doi-asserted-by":"crossref","unstructured":"Sherman SI, Diaz EM Jr, Asper JA, Hoff AO, Wirfel K, Busaidy NL, et al. Parathyroid carcinoma: A 22-year experience. Head Neck. 2004;26(8):716\u201326.","DOI":"10.1002\/hed.20049"},{"issue":"3","key":"1060_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","volume":"86","author":"SA Hundahl","year":"1999","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86(3):538\u201344.","journal-title":"Cancer."},{"issue":"2","key":"1060_CR6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.23736\/S0391-1977.17.02737-7","volume":"43","author":"F Cetani","year":"2018","unstructured":"Cetani F, Pardi E, Marcocci C. Parathyroid carcinoma: a clinical and genetic perspective. Minerva Endocrinol. 2018;43(2):144\u201355.","journal-title":"Minerva Endocrinol"},{"issue":"9","key":"1060_CR7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/cncr.22599","volume":"109","author":"PK Lee","year":"2010","unstructured":"Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2010;109(9):1736\u201341.","journal-title":"Cancer"},{"issue":"2","key":"1060_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1245\/s10434-015-4901-9","volume":"23","author":"CJ Benjamin","year":"2016","unstructured":"Benjamin CJ, Briseis, et al. The Incidence and Survival of Rare Cancers of the Thyroid, Parathyroid, Adrenal, and Pancreas. Ann Surg Oncol. 2016;23(2):424\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"1060_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","volume":"56","author":"EM Ryh Nen","year":"2017","unstructured":"Ryh Nen EM, Leijon H, Metso S, Eloranta E, Korsoff P, Ahtiainen P, et al. A nationwide study on parathyroid carcinoma. Acta Oncol. 2017;56(7):991\u20131003.","journal-title":"Acta Oncol"},{"issue":"006","key":"1060_CR10","first-page":"483","volume":"5","author":"X Xiaoping","year":"2006","unstructured":"Xiaoping X, Ou W, Xunwu M, Weibo X, Mei L, Yan J, et al. Comparison of clinical manifestations in patients with primary hyperparathyroidism between districts of Beijing and New York. J Diagn Concepts Pract. 2006;5(006):483\u20136.","journal-title":"J Diagn Concepts Pract"},{"key":"1060_CR11","volume-title":"Pathology and genetics. Tumours of endocrine organs. World Health Organization Classification of Tumours","author":"R Delellis","year":"2004","unstructured":"Delellis R. Pathology and genetics. Tumours of endocrine organs. World Health Organization Classification of Tumours; 2004."},{"issue":"1","key":"1060_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/his.13306","volume":"72","author":"RA Delellis","year":"2018","unstructured":"Delellis RA, Mangray S. Heritable forms of primary hyperparathyroidism: a current perspective. Histopathology. 2018;72(1):117\u201332.","journal-title":"Histopathology."},{"issue":"18","key":"1060_CR13","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Vlimki S, Obara T, Gaz RD, Arnold A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349(18):1722.","journal-title":"N Engl J Med"},{"issue":"2","key":"1060_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/ijms18020310","volume":"18","author":"V Chiara","year":"2017","unstructured":"Chiara V, Sabrina C. Epigenetic Alterations in Parathyroid Cancers. Int J Mol Sci. 2017;18(2):310.","journal-title":"Int J Mol Sci"},{"key":"1060_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mce.2017.05.010","volume":"469","author":"V Guarnieri","year":"2018","unstructured":"Guarnieri V, Muscarella LA, Verdelli C, Corbetta S. Alterations of DNA methylation in parathyroid tumors. Mol Cell Endocrinol. 2018;469:60\u20139.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1060_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/PAS.0b013e31820371e4","volume":"35","author":"D Nonaka","year":"2011","unstructured":"Nonaka D. Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions. Am J Surg Pathol. 2011;35(1):145\u201351.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1060_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.surg.2017.04.027","volume":"163","author":"M El Lakis","year":"2018","unstructured":"El Lakis M, Nockel P, Guan B, Agarwal S, Welch J, Simonds WF, et al. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has lesser rate of biochemical cure. Surgery. 2018;163(1):31\u20134.","journal-title":"Surgery"},{"issue":"2","key":"1060_CR18","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Mark S, Ve R, Lee HH, Paul N, et al. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab. 2015;100(2):E360\u20134..","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1060_CR19","doi-asserted-by":"publisher","first-page":"e45567","DOI":"10.1371\/journal.pone.0041143","volume":"7","author":"W Ou","year":"2012","unstructured":"Ou W, Chunyan W, Min N, Quancai C, Heng G, Yan J, et al. Novel HRPT2\/CDC73 gene mutations and loss of expression of Parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One. 2012;7(9):e45567.","journal-title":"PLoS One"},{"issue":"6","key":"1060_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","volume":"39","author":"F Cetani","year":"2016","unstructured":"Cetani F, Pardi E, Marcocci C. Update on parathyroid carcinoma. J Endocrinol Investig. 2016;39(6):595\u2013606.","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"1060_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12020-018-1551-2","volume":"60","author":"Y Hu","year":"2018","unstructured":"Hu Y, Zhang X, Cui M, Su Z, Wang M, Liao Q, et al. Verification of candidate microRNA markers for parathyroid carcinoma. Endocrine. 2018;60(2):246\u201354.","journal-title":"Endocrine."},{"issue":"2","key":"1060_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/ERC-18-0480","volume":"26","author":"Z Xiang","year":"2019","unstructured":"Xiang Z, Ya H, Mengyi W, et al. Profiling analysis of long non-coding RNA and mRNA in parathyroid carcinoma. Endocr Relat Cancer. 2019;26(2):163\u201376.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1060_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","volume":"29","author":"LA Erickson","year":"2018","unstructured":"Erickson LA, Mete O. Immunohistochemistry in diagnostic parathyroid pathology. Endocr Pathol. 2018;29(2):113\u201329.","journal-title":"Endocr Pathol"},{"issue":"11","key":"1060_CR24","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00268-009-9999-0","volume":"33","author":"T Okamoto","year":"2009","unstructured":"Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg. 2009;33(11):2343\u201354.","journal-title":"World J Surg"},{"issue":"8","key":"1060_CR25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3346\/jkms.2012.27.8.890","volume":"27","author":"BJ Hyun","year":"2012","unstructured":"Hyun BJ, Jin CH, Yenna L, Kyong MM, Joo PY, Soo SC, et al. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism. J Korean Med Sci. 2012;27(8):890\u20135.","journal-title":"J Korean Med Sci"},{"issue":"9","key":"1060_CR26","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00330-011-2141-3","volume":"21","author":"PS Sidhu","year":"2011","unstructured":"Sidhu PS, Talat N, Patel P, Mulholland NJ, Schulte KM. Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm. Eur Radiol. 2011;21(9):1865\u201373.","journal-title":"Eur Radiol"},{"key":"1060_CR27","first-page":"63","volume":"51","author":"S Antonio","year":"2019","unstructured":"Antonio S, Salcuni F, Cetani V, et al. Parathyroid carcinoma. Best Pract Res Clin Endocrinol Metab. 2019;51:63\u201376.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"1060_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ando.2015.03.016","volume":"76","author":"C Do Cao","year":"2015","unstructured":"Do Cao C, Aubert S, Trinel C, Odou MFO, Bayaram M, Patey M. Parathyroid carcinoma: Diagnostic criteria, classification, evaluation. Annales Dendocrinologie. 2015;76(2):165\u20138.","journal-title":"Annales Dendocrinologie"},{"issue":"3","key":"1060_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","volume":"31","author":"A Schantz","year":"1973","unstructured":"Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31(3):600\u20135.","journal-title":"Cancer."},{"issue":"8","key":"1060_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","volume":"17","author":"L Bondeson","year":"1993","unstructured":"Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol. 1993;17(8):820\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1060_CR31","first-page":"17","volume":"2017","author":"M Tsoli","year":"2017","unstructured":"Tsoli M, Angelousi A, Rontogianni D, Stratakis C, Kaltsas G. Atypical manifestation of parathyroid carcinoma with late-onset distant metastases. Endocrinol Diabetes Metab Case Rep. 2017;2017(1):17\u20130106.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"12","key":"1060_CR32","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1359\/jbmr.081018","volume":"23","author":"C Marcocci","year":"2010","unstructured":"Marcocci C, Cetani F, Bilezikian JP. Parathyroid carcinoma. J Bone Miner Res. 2010;23(12):1869\u201380.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1060_CR33","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/cncr.20089","volume":"100","author":"GL Clayman","year":"2010","unstructured":"Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2010;100(5):900\u20135.","journal-title":"Cancer"},{"issue":"4","key":"1060_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0196-0709(90)90088-D","volume":"11","author":"ST Fyfe","year":"1990","unstructured":"Fyfe ST, Hoover LA, Zuckerbraun L, David GM. Parathyroid carcinoma: clinical presentation and treatment. Am J Otolaryngol. 1990;11(4):268\u201373.","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"1060_CR35","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1210\/jc.2013-2014","volume":"98","author":"Q Zhong-ling","year":"2013","unstructured":"Zhong-ling Q, Chun-gen W, Rui-sen Z, Yan-li X, Quan-yong L. Unusual case of solitary functioning bone metastasis from a \"parathyroid adenoma\": Imagiologic diagnosis and treatment with percutaneous Vertebroplasty\u2014case report and literature review. J Clin Endocrinol Metab. 2013;98(9):3555\u201361.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-020-01060-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T15:49:40Z","timestamp":1670168980000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-01060-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-01060-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-72834\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-72834\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-72834\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-72834\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-72834\/v2","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants. Ethical approval was obtained from the Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University, China, in accordance with the ethical guidelines of the 1975 Declaration of Helsinki. Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor in-Chief of this journal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}